Frost.com - Healthcare Research http://www.frost.com/prod/servlet/svcg.pag/HC00 http://www.frost.com/prod/servlet/svcg.pag/HC00 - Healthcare Research Frost & Sullivan Strategic Analysis of Care Management Markets in Europe http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=171349233 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=171349233 The number of people aged 65 or more is drastically increasing throughout the world. The average Compound Annual Growth Rate (CAGR) of this increase in the number of elderly people in Europe is about 2.1% between 2008 and 2015. The healthcare services to these elderly people are highly demanding in terms of funds and workforce. The care homes that offer long term healthcare services to the elderly, among others, could be nursing homes, residential care homes or sheltered homes. The number of these care homes in Europe is increasing year after year from 2000. Wed, 1 Jul 2009 00:00:00 +0100 U.S. Hip Implant Market http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N60E-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N60E-01-00-00-00 This research service studies the orthopedic hip replacement market in the United States. The market is segmented as primary implants, partial implants and revision implants. It covers the market from the aspects of the driving forces, restraints , trends and reimbursement. Revenue and procedures analysis is provided in the study for a forecast period of 2009-2015. Market share and competitor structure of the market is also discussed. Tue, 30 Jun 2009 12:14:03 +0100 European Mobility Aids Market http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M414-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M414-01-00-00-00 This research service examines the European mobility aids market in terms of the challenges faced by market participants, drivers, and restraints in the industry, the revenue forecasts, growth rates, and strategic recommendations. Tue, 30 Jun 2009 10:41:03 +0100 Genetic Technology Alert. Mechanism behind DNA Repair Discovered; Gene that Regulates Growth of Certain Cancers; Molecule Shuts Down Inflammation and Reverses Damage from SCI http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D6-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D6-00-00 This issue profiles the discovery of the mechanism behind DNA repair, a gene that regulates growth of certain cancers, and a molecule that shuts down inflammation and reverses damage from SCI. Strategic partnership details and some important patents have also been included. Fri, 26 Jun 2009 06:47:48 +0100 Medical and Diagnostic Imaging Technology Alert. High-Resolution Small Sample AFM; Advent of Non or Minimally Invasive Treatment for Brain Tumors; Magnetic Particle Imaging of Nanoparticles Dispersed in Blood Stream http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D860-00-3C-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D860-00-3C-00-00 This issue profiles high-resolution small sample AFM, advent of non or minimally invasive treatment for brain tumors, magnetic particle imaging of nanoparticles dispersed in blood stream. Fri, 26 Jun 2009 01:19:49 +0100 Futuretech Alert. Advances in Heart Valve Repair or Replacement Technologies http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D833-00-9D-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D833-00-9D-00-00 This issue of Futuretech Alert profiles advances in heart valve repair or replacement technologies. Fri, 26 Jun 2009 01:19:49 +0100 Western European Pain Management Devices Markets http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M415-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M415-01-00-00-00 This research service provides a strategic analysis of the western European market for pain management devices. Fri, 26 Jun 2009 00:36:48 +0100 Theranostics: An evolving field catering to the unmet needs of the medical world http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170968864 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170968864 Theranostics is the merger between therapeutics and diagnostics in the form of a DNA test to either predict patient's response to the drug or selection of patient sub-population for clinical trials. Theranostics paves the path for personalised medicine. This involves the use of molecular assays to determine the optimum dose of the drug for the right person at the right time. Fri, 26 Jun 2009 00:00:00 +0100 Molecular testing for infectious diseases - Current dynamics in Europe http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170968957 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170968957 Molecular testing plays an important role in today's disease diagnosis. Gone are the days when physicians relied completely on immunological tests for understanding the disease condition. The advent of amplification technologies such as PCR has dramatically changed the diagnosis space as molecular based analysis of diseases and the causative organisms is becoming a common practice in today's treatment practice. Fri, 26 Jun 2009 00:00:00 +0100 Movers & Shakers Interview with Dr. Charles Potter, CEO, Glide Pharma http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170971423 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170971423 Movers & Shakers Interview with Dr. Charles Potter, CEO, Glide Pharma Fri, 26 Jun 2009 00:00:00 +0100 Frost & Sullivan Awards for InvestFrost Healthcare- European Telemetry and Central Station Monitoring Devices Market Outlook http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=R5C6-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=R5C6-01-00-00-00 Frost & Sullivan Award for Best Strategic Acquisition is presented to the company whose acquisition of the target company was more synergistic and altered the dynamics of the market. The recipient has adopted strategies, post acquisition, to mitigate the problems due to the integration, and is worthy of emulation by other participants. In addition, the recipient has achieved or is on track to achieve its acquisition goals. Thu, 25 Jun 2009 10:45:49 +0100 Getting the United States Healthy http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170888131 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170888131 In the United States, broad economic prosperity, generous veterans benefits, and post-victory euphoria converged together between 1946 and 1964, bringing 76 million newborns into the world. Fifty years later, a different set of forces threatens to affect the way baby boomers make their transition into life's final stage-retirement. Thu, 25 Jun 2009 00:00:00 +0100 U.S. Injectable Drug Pipeline http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N5A1-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N5A1-01-00-00-00 This research service covers the U.S. injectable drug pipeline in 2009. Included are technology trends, Phase III pipeline analysis, selected Phase II and I pipeline analysis. The market is segmented by injectable drug delivery route: subcutaneous injectables, intravenous injectables, intramuscular injectables, and others. Major market challenges, drivers, and restraints and identified and discussed as well as hot topics and trends relating to injectable drug development. Fri, 19 Jun 2009 19:06:57 +0100 Genetic Technology Alert. Study Bolsters Link To Inflammatory Breast Cancer Causal Gene; Molecular Pathway in Prostrate Cancers Indentified; Labeling Technology Enhances the Study of Cell Surface Receptors http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D5-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D5-00-00 This issue profiles identification of a molecular pathway in prostrate cancers by researchers, enhancing the study of cell surface receptors using labeling technology, and recent developments in the research to identify a vaccine for influenza. Strategic partnership details and some important patents have also been included. Fri, 19 Jun 2009 11:54:19 +0100 Medical Devices Technology Alert. Advanced Bone Augmentation Material; Subcutaneous Implantable Defibrillator; Improved Nanobiosensors for SARS Virus Detection http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-8D-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-8D-00-00 This issue profiles an advanced bone augmentation material, a subcutaneous implantable defibrillator, and an improved nanobiosensors for sars virus detection. Fri, 19 Jun 2009 00:20:17 +0100 Technology Innovation to Drive the European Contrast Agents and Radiopharmaceuticals Market? http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170653573 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170653573 With the so-called recession proof healthcare industry taking a beating in the global economic crisis, a majority of the medical devices and technologies have been observing reduced uptake rates. The ripples of the ongoing crisis have also affected the complimentary markets such as contrast agents and radiopharmaceuticals in Europe. Also with the regulatory bodies indicting several contrast agents being responsible for fatal side effects and disorders, the market for contrast agents is expected to suffer. Fri, 19 Jun 2009 00:00:00 +0100 Clip this coupon and get 20% of your next emergency room visit! http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170486209 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170486209 It was bound to happen. The changing focus of healthcare providers to become more 'customer centric.' The bad economy. The reduction in elective procedures. The decline in insurance coverage resulting from rising unemployment. Wed, 17 Jun 2009 00:00:00 +0100 Growth Team Membership 2009 Market Research and Competitive Intelligence Priorities Survey: Creating Insights to Influence Growth http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170342158 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=170342158 Frost & Sullivan's Growth Team Membership recently completed its 2009 survey of Market Research and Competitive Intelligence executives. The executives were asked to identify their most pressing challenges for 2009 so GTM could develop its best-practices research agenda. Tue, 16 Jun 2009 00:00:00 +0100 Western European Market for Compression Therapy http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3D0-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3D0-01-00-00-00 This research service evaluates the compression therapy market in Western Europe. It gives a detailed insight into market challenges, drivers, restraints, key players and the revenue forecasts for the period of 2005-2015. Mon, 15 Jun 2009 19:06:51 +0100 Integration Strategies in the Fragmented Healthcare IT Market in Europe http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M425-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M425-01-00-00-00 This research service analyses various integration strategies in the healthcare IT market in Europe. It explains the various kinds of integration techniques, challenges of the market, regional trends of system integration market in Europe, the advantages of integration and competitive factors in the integration market. It also provides an overview of Microsoft Amalga products. Fri, 12 Jun 2009 19:32:23 +0100 Drug Discovery Technology Alert. Potential Target for Treatment of Bacterial Meningitis; Delivery System for Poor Soluble Drugs Developed; Targetted Therapeutic System Enables Tumor Ablation http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D950-00-1B-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D950-00-1B-00-00 This issue profiles uniquely engineered nanoparticle-mediated drug delivery offered to tumors, a potential target for treatment of bacterial meningitis, and a targetted therapeutic system that enables tumor ablation. Fri, 12 Jun 2009 00:29:18 +0100 Genetic Technology Alert. New Insights into Mitosis Achieved by Slicing Chromosomes; Genetic Test Determines High-Risk Individuals for Heart Surgery Complications; Cellular Matrix for Faster Wound Healing through Biological Principles http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D4-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D4-00-00 This issue profiles new insights into mitosis achieved by slicing chromosomes, genetic test determines high-risk individuals for heart surgery complications, and a cellular matrix for faster wound healing through biological principles. Strategic partnership details and some important patents have also been included. Fri, 12 Jun 2009 00:29:18 +0100 European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M474-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M474-01-00-00-00 This research service analyses the revenue potential for HIV/AIDS and Hepatitis B/C molecular diagnostics markets in major western European countries. It also gives the overview of the market in these regions together with market drivers,restraints and challenges in the whole Europe. Together it recommends strategies for the players in these markets to obtain best results in the European market. Thu, 11 Jun 2009 06:20:23 +0100 Frost & Sullivan Awards for U.S. Pharmaceutical Contract Manufacturing Markets http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=R16C-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=R16C-01-00-00-00 Frost & Sullivan Awards are presented to companies that have exhibited excellence within their industry. This deliverable presents the Frost & Sullivan Awards for the research service: U.S. Pharmaceutical Contract Manufacturing Markets (N16C-52). Tue, 9 Jun 2009 10:26:17 +0100 Decision Support Database - Industry http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=DD06-00-01-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=DD06-00-01-00-00 Mon, 8 Jun 2009 05:38:18 +0100 Computerized Physician Order Entry (CPOE) Systems in Asia Pacific http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=P2AB-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=P2AB-01-00-00-00 This issue based deliverable provides and overview on computerized physician order entry system in Asia Pacific, with 2009 as base year. It provides introduction, impact, implications and Frost & Sullivan recommendation on the Asia Pacific computerized physician order entry (CPOE) system. Sat, 6 Jun 2009 03:37:17 +0100 Medical Devices Technology Alert. Artificial Simulator for Nervous System; Microfluidic Approach To Single Cell Analysis; Micro Device for Monitoring TBI Patients http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-8C-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-8C-00-00 This issue profiles an artificial simulator for the nervous system, a microfluidic approach to single cell analysis, and a micro device for monitoring TBI patients. Fri, 5 Jun 2009 06:36:18 +0100 Genetic Technology Alert. Therapy Targets Translation Initiation Factor in Cancer; Molecular Defect in Hearing Loss Discovered; Discovery of Gene Responsible for Acetaminophen-Induced Liver Injury http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D3-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D3-00-00 This issue profiles a therapy that targets translation initiation factor in cancer, discovery of molecular defect in hearing loss, and discovery of the gene responsible for acetaminophen-induced liver injury. Strategic partnership details and some important patents have also been included. Fri, 5 Jun 2009 05:38:18 +0100 Nutrition Research Alert. Association between Fat Intake and AMD; Consumption of Fruits and Vegetables and Colorectal Cancer Risk; High-Calorie Expenditure Exercise for Cardiac Rehabilitation http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D813-00-6E-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D813-00-6E-00-00 This week's issue of Nutrition Research Alert contains articles on the association between fat intake and AMD, consumption of fruits and vegetables and colorectal cancer risk, and high-calorie expenditure exercise for cardiac rehabilitation. Fri, 5 Jun 2009 04:20:18 +0100 Global Diabetes Market http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3C7-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3C7-01-00-00-00 This research services details the market drivers, restraints, challenges, revenue forecasts of the insulin and the no-insulin market segments of the global diabetes market. It also deals with regional analysis of the US, Europe, Japan and rest of the world markets. Thu, 4 Jun 2009 06:20:21 +0100 North American Home Health Care and Disease Management Markets for Remote Patient Monitoring http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N5BA-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N5BA-01-00-00-00 This research service analyzes market trends in the North American home health care and disease management markets since 2005, predicts future changes in market measurements through 2015, and discusses specific challenges facing industry participants and strategic recommendations targeted to overcome these challenges. The major technology segments covered are home health care and disease management monitoring equipment. Market revenues and unit shipments are presented and discussed and sub-segmented by these different settings. Tue, 2 Jun 2009 13:27:18 +0100 Can PPPs in South Africa's healthcare sector be exploited? http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=169251989 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=169251989 The healthcare industry in South Africa faces substantial challenges, including vast inequalities in access to care. The public sector is responsible for serving approximately 85.0% of the population, yet accounts for around only 49.0% of healthcare spend. Public sector hospitals are plagued by allegations of mismanagement, inadequate financing and human capital constraints. In contrast to this, the private sector accounts for approximately 51.0% of total health expenditure, yet serves only 15.0% of the population. Tue, 2 Jun 2009 00:00:00 +0100 European C-Arms Market http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3D1-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3D1-01-00-00-00 The C-Arms Market in Europe is analyzed Sat, 30 May 2009 19:51:17 +0100 European Markets for Parkinson's Disease Therapeutics http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M32D-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M32D-01-00-00-00 This research service discusses the market for Parkinson's disease. It analyses the various opportunities, recent developments, drug classes and gives a revenue forecasts. Sat, 30 May 2009 10:43:19 +0100 Genetic Technology Alert. Key Molecule Contributing To Blood Cell Development Discovered; Nanoparticle That Can Target and Disable Tumor Cells; ERT Slows Deterioration of Kidney Function http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D2-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D2-00-00 This issue profiles the discovery of a key molecule that contributes to blood cell development, nanoparticles that can target and disable tumor cells, and ezyme replacement therapy that slows the deterioration of kidney function. Strategic partnership details and some important patents have also been included. Fri, 29 May 2009 04:34:18 +0100 Medical Imaging Industry Outlook - 2009 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3CE-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3CE-01-00-00-00 This segment provides the economic outlook of the medical imaging industry in Europe. Fri, 29 May 2009 01:39:19 +0100 Movers & Shakers Interview With Victor Ferrari - CEO, Horphag Research Ltd. http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=168960020 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=168960020 we will have to go a little back in time because it explains some of the strength and quality of the product that we have today. Thu, 28 May 2009 00:00:00 +0100 Maximising Value in the Pharmaceutical Sector - Analysing the Options http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=168891467 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=168891467 The pharmaceutical industry is one of the sectors witnessing growth even during recession times. The big pharma companies are however under immense pressure in terms of intensifying competition, spiralling developmental costs, regulatory barriers, decreasing revenues due to generics, staggering pipelines, patent expirations and unstable share prices. These factors are driving pharma companies to search for options to maximise value. Wed, 27 May 2009 00:00:00 +0100 Increasing scope of Telehealth markets in Europe - A Concise Analysis http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=168892280 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=168892280 Telehealth is defined as healthcare service, consultation and expertise delivered via telecommunications medium, over any distance. Service delivery could be done real-time or stored and broadcasted through media ranging from simple telephonic conversations and internet to video conferencing across boundaries. Wed, 27 May 2009 00:00:00 +0100 Strategic Analysis of the European Markets for Theranostics http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3C3-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3C3-01-00-00-00 This strategic analysis service provides a detailed analysis of the European theranostics market. An indepth analysis of marketing parameters coupled with competitive factors and strategies for sustained market prevalence are reported. Tue, 26 May 2009 09:38:18 +0100 Genetic Technology Alert. Encapsulation for Efficient Delivery of Stem Cells; Orphan Receptors Could be Drug Targets for Sleep Disorders; Identifying Genetic Cause of Luminal Breast Cancer http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D1-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D1-00-00 This issue profiles encapsulation for efficient delivery of stem cells, orphan receptors that could be drug targets for sleep disorders, and identifying genetic cause of luminal breast cancer. Strategic partnership details and some important patents have also been included. Fri, 22 May 2009 00:24:18 +0100 Medical Devices Technology Alert. Microneedle Skin Patch Design for Painless Flu Vaccine Delivery; Drug Delivery through Nanotubes on the Implant Surface; Capsule for Early Detection of Colorectal Cancer http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-8B-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-8B-00-00 This issue profiles microneedle skin patch design for painless flu vaccine delivery, drug delivery through nanotubes on the implant surface, and capsule for early detection of colorectal cancer. Fri, 22 May 2009 00:12:56 +0100 InvestFrost Healthcare - Western European Cardiac Rhythm Management Market http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N604-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N604-01-00-00-00 This research deliverable presents an overview of the European Cardiac Rhythm Management Market. Key points point out the market definitions and the abbreviation used in this deliverable. Dynamics of the Telemetry and Central Station Monitoring Markets presents an understanding of the present market conditions with revenue predictions and a snapshot of the challenges and drivers, restraints facing this market. Investment themes present the key reasons as to why an investor should consider investing in this market. Concluding thoughts presents the country rankings based on various parameters and suggests the author's final thoughts on the market. Thu, 21 May 2009 11:12:19 +0100 European Patient Monitoring Market Outlook- 2009 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3B2-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3B2-01-00-00-00 This research service examines the European patient monitoring market in terms of the challenges faced by market participants, drivers, and restraints in the industry, the market share analysis, the revenue forecasts, growth rates, as well as future outlook. Thu, 21 May 2009 01:39:17 +0100 Upcoming SMi Event: In Vitro Diagnostics http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=168354145 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=168354145 Thu, 21 May 2009 00:00:00 +0100 European Lab-on-chip and Microfluidics Markets http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3C0-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3C0-01-00-00-00 This research service gives a detailed analysis of the lab-on-chip and microfluidics market in Europe from 2005-2015. Wed, 20 May 2009 10:47:18 +0100 Western European Wound Closure Market http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M391-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M391-01-00-00-00 The objective of this research service is to provide detailed analysis of the largely stable European Wound Closure market. This service provides an in-depth analysis of the market split into four segments - sutures, mechanical wound closure devices, wound strips and skin adhesives. The research service discusses revenues, unit shipments, pricing trends and the competitive landscape for each segment. It also provides strategies for companies involved in the wound closure market. Additionally, the research service provides decision support databases related to hospital resources and healthcare expenditure. Wed, 20 May 2009 06:23:17 +0100 Market Opportunities in Biologics http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=168094901 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=168094901 Mon, 18 May 2009 00:00:00 +0100 Medical and Diagnostic Imaging Technology Alert. Accurate Imaging Tool for Prostate Cancer; Cell Therapy for Enhancing Vessel Growth in PAD; Important Advancements in Brain Mapping http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D860-00-3B-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D860-00-3B-00-00 This issue profiles an accurate imaging tool for prostate cancer; cell therapy for enhancing vessel growth in peripheral arterial disease, and important advancements in brain mapping. Fri, 15 May 2009 23:05:17 +0100 Genetic Technology Alert. Neuroprotective Gene for Amyotrophic Lateral Sclerosis; Genes Associated with Disc Degeneration; Test for Detecting Swine Flu Developed http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D0-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-D0-00-00 This week's issue of GTN Alert profiles a neuroprotective gene for amyotrophic lateral sclerosis, genes associated with disc degeneration, and a test for detecting swine flu. Strategic partnership details and some important patents have also been included. Fri, 15 May 2009 06:20:48 +0100 Swine Flu and its Impact on Medical Devices Market http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=167804591 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=167804591 Swine flu is a highly contagious respiratory disease originating in pigs. These strains when transferred to humans, can cause influenza like symptoms and be life threatening in severe cases. Fri, 15 May 2009 00:00:00 +0100 U.S. Compression Therapy Market http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N5D4-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N5D4-01-00-00-00 This research service covers the U.S. compression therapy market in the United States. Further, market dynamics and revenue forecasts and analysis, and competitive landscape have been discussed for each of the segments static and dynamic compression therapy. Thu, 14 May 2009 14:13:18 +0100 Growth Team Membership 2009 Corporate Strategy and Corporate Development Priorities Survey: Growth in a recession: a strategic balancing act http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=167492136 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=167492136 Frost & Sullivan's Growth Team Membership recently completed its 2009 survey of Corporate Strategy and Corporate Development executives. Executives were asked to identify their most pressing challenges for 2009 so GTM could develop its best-practices research agenda. Wed, 13 May 2009 00:00:00 +0100 Mergers and Acquisitions in the Pharma-Biotech Industry http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3DD-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3DD-01-00-00-00 This research service provides insights into M&A activities, trends and strategic analysis in the pharma- biotech space. Mon, 11 May 2009 23:39:19 +0100 Frost & Sullivan Awards for Western European Wound Closure Market http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=Q391-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=Q391-01-00-00-00 The research service provides a detailed description of the awards presented to different companies. The awards have been conferred to companies for their best practices in various categories including Growth Strategy Leadership Award, Industry Innovation & Advancement Award and Product Quality Leadership Award. It further describes the criteria to be fulfilled and the methodology involved in nominating the various companies for the awards. Sat, 9 May 2009 10:03:48 +0100 Opportunities in Predictive Drug Discovery and the Use of In-Silico Tools http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3ED-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M3ED-01-00-00-00 This short issue based research provides a top level picture of the applications of in-silico tools within the drug discovery market in Europe. Fri, 8 May 2009 10:50:49 +0100 Frost & Sullivan Awards for European Market for Non- invasive Ventilation and Associated Airway Management Devices http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=Q32F-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=Q32F-01-00-00-00 This award deliverable provides a description of the awards presented to various companies in the European Market for Non - invasive Ventilation and Associated Airway Management Devices. Awards such as Growth Strategy Leadership and Product Quality Leadership has been presented to the deserving companies that follow best practice in the particular domain.The research service also discusses award nomination criteria and methodology involved for the same. Fri, 8 May 2009 10:44:49 +0100 Nutrition Research Alert. Folate Status in Swedish Women; Beverages and Triglyceride Levels; Lycopene Lowers Metabolic Syndrome Incidence http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D813-00-6D-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D813-00-6D-00-00 This week's issue of Nutrition Research Alert contains articles on folate status in Swedish women, beverages and triglyceride levels, and effect of lycopene on metabolic syndrome incidence. Fri, 8 May 2009 06:08:48 +0100 Genetic Technology Alert. Role of Platelets in Sepsis; Combined Functioning of Three Factors Holds the Key To Cardiac Differentiation; HE4 Test could Detect Ovarian Cancer at an Early Stages http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-CF-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-CF-00-00 This week's issue of GTN Alert profiles the role of platelets in sepsis, combined functioning of three factors holds the key to cardiac differentiation, HE4 test could detect ovarian cancer at an early stages. Strategic partnership details and some important patents have also been included. Fri, 8 May 2009 05:24:51 +0100 Medical Devices Technology Alert. Wireless Swimming Microrobots; New Noninvasive Test for Assessment of Muscle Degeneration; Lab-on-a-Chip-Based Diagnostic Tool for Malaria http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-8A-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-8A-00-00 This issue profiles wireless swimming microrobots, new noninvasive test for assessment of muscle degeneration, lab-on-a-chip-based diagnostic tool for malaria. Fri, 8 May 2009 04:16:49 +0100 Drug Discovery Technology Alert. Naked Liposomes May Help Treating Osteoarthritis; Statins Lower Cholesterol in the Brain; Personalized Medicine Initiative in CML http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D950-00-1A-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D950-00-1A-00-00 This issue profiles naked liposomes that may help in treating osteoarthritis, statins that lower cholesterol in the brain, and a personalized medicine initiative in CML. Fri, 8 May 2009 02:32:48 +0100 APAC Medical Imaging http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=P2AA-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=P2AA-01-00-00-00 The research service provides an overview of the convergence between medical imaging and IT in Asia Pacific medical imaging with 2009 as the base year. It provides an introduction, impact, implications and Frost & Sullivan recommendation on the convergence between medical imaging and IT. Wed, 6 May 2009 19:51:48 +0100 2nd Annual Observational Research to Demonstrate Drug Safety http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=166779518 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=166779518 Frost & Sullivan is media partner for this event, which will be examining the growing role of non-interventional research in achieving stronger safety results, and higher drug performance. Focusing on the methodological and operational aspects delegates will be exposed to some of the most cutting-edge case studies in the area. Tue, 5 May 2009 00:00:00 +0100 Best Practice in API Manufacturing Project Management http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=166779948 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=166779948 Frost & Sullivan is media partner for this event, which will look at the key issues surrounding effective implementation of new API manufacturing projects, whether in-house or outsourced, from design to project close. Tue, 5 May 2009 00:00:00 +0100